Sterility testing is a critical aspect of quality control in industries such as pharmaceuticals, biotechnology, and medical devices. It ensures that products are free from viable microorganisms, including bacteria, fungi, and viruses. Companies specializing in sterility testing typically offer services that adhere to regulatory standards and guidelines to guarantee the safety and efficacy of the products they test.
Latest Sterility testing Companies Update
July 2023: Ten23 Health recently introduced quality control (QC) services in Switzerland, which are designed to conduct stability and release testing of sterile commercial and clinical drug products in accordance with international cGMP standards. Two locations of ten23 will house the new quality control division in order to accommodate a variety of testing needs and to ensure that each location is in optimal harmony with our other offerings. In Basel ten23 Health, physico-chemical testing, including identity, purity, and content, will be provided in accordance with pharmacopeial standards to assure the stability and release of sterile pharmaceutical drug products intended for clinical and commercial use. Ten23 will incorporate these services with the pharmaceutical development service it offers in Basel. The pharmaceutical industry's partner headquartered in Basel has established a new quality control (QC) division to assist in the release and stability testing of sterile drug products for commercial and clinical use, in accordance with international cGMP standards.
November 2023: MilliporeSigma, a life science enterprise of Merck KGaA, Darmstadt, operating in the United States and Canada, introduced ChemisTwinTM, the first digital reference materials platform capable of employing calibrated algorithm-based digital references for automated analysis of sample purity, identification, and degradation of compounds. By utilizing digital signatures for over 1,500 reference materials, this automation and calibration instrument aids scientists in guaranteeing the safety and quality of pharmaceuticals throughout the entire research and development process, including quality control and assurance testing. Life sciences are being disrupted by the expanding use of digital technologies that are supported by high-quality data. The ability to digitize reference materials represents an enormous advance in the protection of consumer goods and medications around the globe. The user-friendly and intuitive nature of ChemisTwinâ„¢ facilitates the progression of scientific inquiry, product innovation, quality assurance, and adherence to regulatory standards.
Intended Audience
Figure 1:- EMEA sterility testing market share, by region 
Sources: WHO, annual reports, press release, white paper, and company presentation
The EMEA sterility testing market is segmented on the basis of product, test, application and end users.
The EMEA sterility testing market is segmented into kits & reagents, services, instruments, and others.
The market is segmented into membrane filtration, direct inoculation sterility testing, and others. The membrane filtration segment is sub-segmented into membrane type which is further segmented into synthetic organic polymers and inorganic materials. The synthetic organic polymers, by membrane type, is sub-segmented into polysulfone, cellulose acetate, and others. The inorganic materials, by membrane type, is sub-segmented into ceramic membranes, metal membranes, others.
The market is segmented into pharmaceutical industries, biotechnology industries, and others.
The market is segmented into hospitals & clinics, academic institutes, research organization, and others.Â
Europe is the largest sterility testing market. High healthcare expenditures, government support for research & development and huge patient population drives the European market. Moreover, growing biotechnology and pharmaceutical industries is boosting the market growth. Additionally, the presence of the developed economies within the region like the U.K and France is fuelling the market growth during the forecast period. Regionally Europe is divided into Western Europe and Eastern Europe. Western Europe leads the market within the region. On the other hand, there are huge opportunities for the market growth in Eastern Europe.Â
Asia Pacific is the fastest growing region in EMEA market due to the presence of a huge patient population and continuously developing economies like India and China which have a growing healthcare industry. According to the Indian Brand Equity Foundation, in 2017, the Indian healthcare sector is one of the fastest growing industries and is expected to advance at a CAGR of 22.8% and reach USD 280 billion by 2020. Additionally, favorable government policies like reduced excise and customs duty followed by the exemptions in service tax in India boosts the regional market growth.Â
The Middle East & Africa holds the least share in the EMEA sterility testing market due to the presence of poor economies in the African region owing to the low per capita income and stringent government policies within the region. A majority of the Middle East & Africa market is held by the Middle East due to huge healthcare expenditures and presence of developed economies like Kuwait, Saudi Arabia, Dubai, and Qatar. Â
Research Methodology 
Sources: WHO, annual reports, press release, white paper, and company presentation
Key players for EMEA sterility testing market
Some of the major players in the EMEA sterility testing market are Merck KGaA (Germany), bioMérieux SA (France), SGS SA (Switzerland), Sartorius AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Toxikon, Inc. (U.S.), Charles River (U.S.), and others.
Europe Sterility Testing Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)